• DOI:10.1517/14656566.8.6.797
Corpus ID: 24196381

Chemotherapy for advanced gastric cancer: across the years for a standard of care

@article{Scartozzi2007ChemotherapyFA,
  title={Chemotherapy for advanced gastric cancer: across the years for a standard of care},
  author={M. Scartozzi and E. Galizia and L. Verdecchia and R. Berardi and S. Antognoli and S. Chiorrini and S. Cascinu},
  journal={Expert Opinion on Pharmacotherapy},
  year={2007},
  volume={8},
  pages={797 - 808}
}

M. Scartozzi, E. Galizia, +4 authors S. Cascinu

Published 2007

Medicine

Expert Opinion on Pharmacotherapy

Chemotherapy is of crucial importance in advanced gastric cancer patients, in order to obtain palliation of symptoms and improve survival. The most extensively studied drugs as single agents are 5-fluorouracil, cisplatin, doxorubicin, epirubicin, mitomycin C and etoposide. Newer chemotherapeutic agents include the taxanes (docetaxel and paclitaxel), oral fluoropyrimidines (capecitabine and S-1), oxaliplatin and irinotecan. Randomised trials comparing monotherapy with combination regimens have… CONTINUE READING

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed